Saunders Brent L
SEC-identified person · CIK 1268854 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Silverback Therapeutics, Inc. SPRY | Director | filed 2022 - 2026 |
| Bausch & Lomb Corp BLCO | Director · Chairman of the Board and CEO | filed 2023 - 2026 |
| Vesper Healthcare Acquisition Corp. VSPRU | Director · President, CEO and Chairman | filed 2020 - 2025 |
| Cisco Systems, INC. CSCOI | Director | filed 2017 - 2022 |
| Bridgebio Pharma, Inc. BBIO | Director | filed 2020 - 2022 |
| Allergan plc AGN | Director · Chairman, President and CEO | filed 2014 - 2020 |
| Forest Laboratories, LLC frx | Director · CEO & President | filed 2011 - 2014 |
| Schering Plough Corp SGP | Senior Vice President | filed 2006 - 2009 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.